A meta-analysis suggests that abiraterone or apalutamide added to androgen deprivation therapy for men with metastatic castration-sensitive prostate cancer offers the best overall survival.
Elevated levels of 3 immune system biomarkers are associated with an increased risks for kidney failure requiring renal replacement therapy and death, a study found.
Removing the race coefficient from the CKD-EPI equation could avert a potential systematic delay in kidney transplant eligibility of a median 1.9 years for Black patients, according to investigators.
With the advent of more reliable and accurate ways to screen for prostate cancer, such as PSA testing and prostate MRI, the authors argue that it is time to stop the “antiquated practice” of the digital rectal examination.
A study of patients with ADPKD found that each 1 mmol/L decrease in serum bicarbonate was significantly associated with a 21% increased risk for worsening kidney function.
In a trial of patients with primary membranous nephropathy, corticosteroid-cyclophosphamide induced significantly more and faster remission of nephrotic syndrome than tacrolimus-rituximab.